Fast Saliva Test for H.I.V. Gains Federal ApprovalBy Donald G. McNeil Jr.PRINT EDITIONMarch 27, 2004, Page A00008

Scientists Urge More Study On a Rare Strain of H.I.V.By Donald G. McNeil Jr. and Lawrence K. AltmanPRINT EDITIONFebruary 13, 2005, Page 1039

Study finds circumcision reduces AIDS risk - Health & Science - International Herald TribuneBy Donald G. McNeil Jr.PRINT EDITIONDecember 13, 2006

Circumcision appears to reduce AIDS risk from sex in men - Health & Science - International Herald TribuneBy Donald G. McNeil Jr.PRINT EDITIONDecember 14, 2006

Circumcision Halves H.I.V. Risk, U.S. Agency FindsExperts cautioned that circumcision is no cure-all. It only lessens the chances that a man will contract AIDS from heterosexual sex.By Donald G. McNeil Jr.PRINT EDITIONH.I.V. RISK HALVED BY CIRCUMCISION, U.S. AGENCY FINDS|Page A1

Circumcision’s Anti-AIDS Effect Found Greater Than First ThoughtFinal data from two clinical trials in Africa suggest that circumcision reduces a man’s risk of contracting H.I.V. by as much as 65 percent — more than suspected when the two trials were stopped because the results were so clear.By Donald G. McNeil Jr.PRINT EDITIONPage A3

Study finds possible targets for AIDS drugsBy Donald G. Mcneil Jr.PRINT EDITIONJanuary 1, 2008

Talking With Children About Sex and AIDS: At What Age to Start?What age is the right age to have “the talk,” not just about where babies come from, but also about sex and AIDS?By Donald G. McNeil Jr.PRINT EDITIONPage F5

Rare Treatment Is Reported to Cure AIDS PatientDoctors reported curing a man of AIDS by giving him blood stem cells from a person resistant to the virus.By Donald G. McNeil Jr.PRINT EDITIONAIDS Patient Is Reported Cured in Berlin With a Rare Treatment|Page A12

AIDS patient is reported curedBy Donald G. Mcneil JrPRINT EDITIONNovember 14, 2008

For First Time, AIDS Vaccine Shows Some SuccessA new AIDS vaccine tested in Thailand has protected a significant minority against infection.By Donald G. McNeil Jr.PRINT EDITIONVaccine for AIDS Passes Trial; Limits of Success to Be Studied|September 25, 2009, Page A1

Success of AIDS Vaccine Trial Is at IssueData released last month showing an AIDS vaccine’s promise are weaker than believed, reports find.By Donald G. McNeil Jr.PRINT EDITIONOctober 11, 2009, Page A33

AIDS Vaccine Trial Shows Only Slight ProtectionThe full results from a trial in Thailand showed that the vaccine’s protective effect might be even weaker than researchers first admitted.By Donald G. McNeil Jr.PRINT EDITIONThai Trial for AIDS Vaccine Shows Only Slight Protection|October 21, 2009, Page A10

At Front Lines, AIDS War Is Falling ApartUganda is the first and most obvious example of how the war on AIDS is falling apart as cases rise and global priorities shift.By Donald G. McNeil Jr.PRINT EDITIONAt Front Lines, Global War on AIDS Is Falling Apart|May 10, 2010, Page A1

After Long Scientific Search, Still No Cure for AIDSDespite decades of effort, no magic bullet for AIDS has been invented. Even in wealthy countries, it can only be controlled, not cured.By Donald G. McNeil Jr.PRINT EDITIONAfter Long Scientific Search, a Cure Is Still Elusive|May 10, 2010, Page A10

Advance on AIDS Raises Questions as Well as JoyExperts are pondering issues raised after a trial found that a vaginal gel could help women avoid infection.By Donald G. McNeil Jr.PRINT EDITIONJuly 27, 2010, Page D1

Daily Pill Greatly Lowers AIDS Risk, Study FindsAn antiretroviral drug that is already available proved more than 90 percent effective for faithful users.By Donald G. McNeil Jr.PRINT EDITIONSTUDY FINDS PILL GREATLY LOWERS THE RISK OF AIDS|November 24, 2010, Page A1

Early H.I.V. Therapy Sharply Curbs TransmissionIn a large clinical trial, patients who were treated before the virus seriously damaged their immune systems were 96 percent less likely to pass it on.By Donald G. McNeil Jr.PRINT EDITIONEarly Therapy For H.I.V. Said To Cut Spread|May 13, 2011, Page A1

New H.I.V. Cases Steady Despite Better TreatmentThe number of new infections has remained around 50,000 a year for a decade in the United States, but the epidemic is growing rapidly worse among young gay black men.By Donald G. McNeil Jr.PRINT EDITIONNew H.I.V. Cases Remain Steady Over a Decade|August 4, 2011, Page A16

Clinton Aims for ‘AIDS-Free Generation’Secretary of State Hillary Rodham Clinton outlined an ambitious worldwide agenda but offered few details on how to pay for it.By Donald G. McNeil Jr.PRINT EDITIONNovember 9, 2011, Page A16

Trial Vaccine Made Some More Vulnerable to H.I.V., Study ConfirmsIn 2007, a trial of an AIDS vaccine made by Merck was stopped early when it became clear that it was not protecting everyone. Now a follow-up study has confirmed the worst fears of researchers.By Donald G. McNeil Jr.

Rapid H.I.V. Home Test Wins Federal ApprovalThe OraQuick test, which uses a mouth swab and gives results in 20 to 40 minutes, is the first method for Americans to learn in the privacy of their own homes whether they are infected.By Donald G. McNeil Jr.PRINT EDITIONF.D.A. Approves Rapid H.I.V. Test For Use At Home|July 4, 2012, Page A1

In Washington, H.I.V. Testing Moves Beyond the ClinicThe District of Columbia, with one of the nation’s worst infection rates, is offering tests in grocery stores, high schools and motor vehicle offices — and paying people to take them.By Donald G. McNeil Jr.PRINT EDITIONTesting for H.I.V. at Stores, on Street Corners and at the Motor Vehicle Office|July 22, 2012, Page A12

Another Use for Rapid Home H.I.V. Test: Screening Sexual PartnersAn unadvertised use for the OraQuick test may become popular and even help slow the AIDS epidemic, experts said.By Donald G. McNeil Jr.PRINT EDITIONOctober 6, 2012, Page A14

A Weak Spot in H.I.V.’s Armor Raises Hope for a VaccineResearchers announced that they had found a vulnerable spot on the virus’s outer shell that might present a good vaccine target.By Donald G. McNeil Jr.PRINT EDITIONOctober 30, 2012, Page D5

In Medical First, a Baby With H.I.V. Is Deemed CuredThe baby, born in rural Mississippi, was treated aggressively with antiretroviral drugs starting around 30 hours after birth; if further study shows this treatment works, it will almost certainly be recommended globally.By Andrew Pollack and Donald G. McNeil Jr.PRINT EDITIONMarch 4, 2013, Page A1

‘Cured of AIDS’? Not YetThere is no way of knowing which H.I.V. patients might kill the virus before it sinks deeper into their bodies, but experts agree on the clear benefits of early treatment.By Donald G. McNeil Jr.PRINT EDITIONApril 30, 2013, Page D1

After Marrow Transplants, 2 More Patients Appear H.I.V.-Free Without DrugsTwo H.I.V.-infected patients who had bone-marrow transplants for blood cancers have apparently been virus-free since they stopped taking antiretroviral drugs.By Donald G. McNeil Jr.PRINT EDITIONJuly 4, 2013, Page A10

New Hope for H.I.V. VaccineA new vaccine tested in monkeys generated a muted immune response that effectively wiped out cells infected with simian immunodeficiency virus, a close relative of H.I.V.By Donald G. McNeil Jr.PRINT EDITIONSeptember 17, 2013, Page D3

Marrow Transplants Fail to Cure Two H.I.V. PatientsResearchers expressed frustration after two men who had been treated with bone-marrow procedures saw their H.I.V. return.By Donald G. McNeil Jr.PRINT EDITIONMarrow Transplants Fail To Cure Two H.I.V. Patients|December 7, 2013, Page A13

Injections Providing Protection Against AIDS in Monkeys, Studies FindVersions of already approved drugs kept the monkeys infection-free for weeks, and researchers hope that a dose every three months could work in humans.By Donald G. McNeil Jr.PRINT EDITIONMarch 5, 2014, Page A19

Early Treatment Is Found to Clear H.I.V. in a 2nd BabyAnother baby born with H.I.V. and treated with drugs shortly after birth is now 9 months old and apparently H.I.V.-negative. The success of the treatment raises hopes for a path to rid babies of the virus that causes AIDS.By Donald G. McNeil Jr.PRINT EDITIONEarly Treatment Found to Clear H.I.V. in 2nd Baby|March 6, 2014, Page A1

Advocating Pill, U.S. Signals Shift to Prevent AIDSFederal health officials recommended that hundreds of thousands of Americans at risk for AIDS take a daily pill shown to prevent infection with the virus that causes it.By Donald G. McNeil Jr.PRINT EDITIONMay 15, 2014, Page A1

Evidence of H.I.V. Found in a Child Said to Be CuredThe apparent cure had raised the thrilling possibility that aggressive early treatment might be able to reverse infections in newborns — and perhaps even in newly infected adults.By Donald G. McNeil Jr.PRINT EDITIONJuly 11, 2014, Page A1

New Approach to Blocking H.I.V. Raises Hopes for an AIDS VaccineA new compound has blocked H.I.V. infection so well in monkeys that it may be able to function as a vaccine against AIDS, scientists say.By Donald G. McNeil Jr.PRINT EDITIONFebruary 19, 2015, Page A17

H.I.V. Treatment Should Start at Diagnosis, U.S. Health Officials SayFederal health officials announced the new guidelines after a clinical trial showed pronounced benefits for people put on antiretroviral drugs as soon as they learned they were infected.By Donald G. McNeil Jr.PRINT EDITIONScientists Urge a Prompt Start of H.I.V. Drugs|May 28, 2015, Page A1

Daily H.I.V. Drug Regimen Is Effective in African Women, Study SaysA study found that 76 percent of young women in Cape Town, South Africa, who were assigned to take Truvada, a H.I.V.-prevention drug, were willing and able to take the pills daily.By Donald G. McNeil Jr.PRINT EDITIONJuly 23, 2015, Page A18

Insurer Says Clients on Daily Pill Have Stayed H.I.V.-FreeThe finding contradicts critics’ predictions that pre-exposure prophylaxis, or PrEP, would lead to less condom use and more H.I.V. infections.By Donald G. McNeil Jr.PRINT EDITIONInsurer Says Clients on a Daily Pill Have Stayed Free of H.I.V. for Two Years|September 3, 2015, Page A22

San Francisco Is Changing Face of AIDS TreatmentThe city that was once the epidemic’s ground zero now has only a few hundred new cases a year, the result of a raft of creative programs.By Donald G. McNeil Jr.PRINT EDITIONCity Versus Epidemic|October 6, 2015, Page D1

H.I.V. Arrived in the U.S. Long Before ‘Patient Zero’The virus appeared in New York as early as 1971, according to a new genetic analysis, and spread from there to San Francisco.By Donald G. McNeil Jr.PRINT EDITIONH.I.V. Was in the U.S. Long Before ‘Patient Zero’|October 27, 2016, Page A1

Scientists Report a Rare Case of H.I.V. RemissionA girl in South Africa, born infected with the virus, was given early treatment and remained free of the infection eight years later, scientists reported on Monday.By Donald G. McNeil Jr.PRINT EDITIONJuly 25, 2017

As Cancer Tears Through Africa, Drug Makers Draw Up a Battle PlanIn a deal similar to the one that turned the tide against AIDS, manufacturers and charities will make chemotherapy drugs available in six poor countries at steep discounts.By Donald G. McNeil Jr.PRINT EDITIONFighting a Death Sentence|October 10, 2017, Page D1

He Took a Drug to Prevent AIDS. Then He Couldn’t Get Disability Insurance.Insurers have denied life and disability coverage to men taking Truvada to prevent H.I.V. infection, say gay rights advocates and medical experts.By Donald G. McNeil Jr.PRINT EDITIONPolicy vs. Prevention|February 13, 2018, Page D1

Vaccines Against H.I.V., Malaria and Tuberculosis Unlikely, Study SaysUnless the $3 billion spent annually on research triples, the world may not be able to invent vaccines or rapid cures for many ills of the poor.By Donald G. McNeil Jr.PRINT EDITIONMoney Needed to Develop Vaccines, Study Says|September 11, 2018, Page D3

Someday, an Arm Implant May Prevent H.I.V. Infection for a YearIn preliminary tests, a matchstick-size rod containing a new drug offered promise as a shield against the virus. But a large clinical trial must still be done.By Donald G. McNeil Jr.PRINT EDITIONSomeday, an Implant in the Arm Could Prevent H.I.V. Infection for One Year|July 24, 2019, Page A8

Another H.I.V. Vaccine Fails a Trial, Disappointing ResearchersAfter more than 30 years of research, 1.7 million people are still infected each year with the virus that causes AIDS.By Donald G. McNeil Jr.PRINT EDITIONFebruary 5, 2020

‘We Loved Each Other’: Fauci Recalls Larry Kramer, Friend and NemesisIn public, the activist berated the infectious disease expert for federal inaction on AIDS. But their affection lasted decades and changed the course of the epidemic.By Donald G. McNeil Jr.PRINT EDITIONMay 28, 2020